Literature DB >> 21995408

The avastin story.

Mikkael A Sekeres.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21995408     DOI： 10.1056/NEJMc1109550

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.

Authors:  Steven E Lipshultz; Melissa B Diamond; Vivian I Franco; Sanjeev Aggarwal; Kasey Leger; Maria Verônica Santos; Stephen E Sallan; Eric J Chow
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022

2.  Bevacizumab induces A549 cell apoptosis through the mechanism of endoplasmic reticulum stress in vitro.

Authors:  Li-Le Wang; Rui-Cheng Hu; Ai-Guo Dai; Shuang-Xiang Tan
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Targeting angiogenesis in metastatic breast cancer.

Authors:  Sangeetha Reddy; Michael Raffin; Virginia Kaklamani
Journal:  Oncologist       Date:  2012-07-27

Review 4.  The Role of Wnt Signalling in Angiogenesis.

Authors:  Jun Jun Olsen; Sebastian Öther-Gee Pohl; Abhijeet Deshmukh; Malini Visweswaran; Natalie C Ward; Frank Arfuso; Mark Agostino; Arun Dharmarajan
Journal:  Clin Biochem Rev       Date:  2017-11

5.  New treatment options for lupus - a focus on belimumab.

Authors:  Laurent Chiche; Noémie Jourde; Guillemette Thomas; Nathalie Bardin; Charleric Bornet; Albert Darque; Julien Mancini
Journal:  Ther Clin Risk Manag       Date:  2012-01-26       Impact factor: 2.423

6.  Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study.

Authors:  Agnes Vitry; Tuan Nguyen; Vikky Entwistle; Elizabeth Roughead
Journal:  J Pharm Policy Pract       Date:  2015-10-19

Review 7.  Antibody variable region engineering for improving cancer immunotherapy.

Authors:  Hantao Lou; Xuetao Cao
Journal:  Cancer Commun (Lond)       Date:  2022-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.